Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates – ABC News

A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:

• The study involved 800 severely ill COVID-19 patients
• The UK Government said the drugs will be used to treat critically ill COVID-19 patients
• Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly

The findings, which have not yet been…

Click here to view the original article.